These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20079662)

  • 21. The influence of clean room design on product contamination.
    Whyte W
    J Parenter Sci Technol; 1984; 38(3):103-8. PubMed ID: 6747777
    [No Abstract]   [Full Text] [Related]  

  • 22. Current practices in the validation of aseptic processing--1992.
    Agalloco J; Akers J
    J Parenter Sci Technol; 1993; 47 Suppl 1():S1-21. PubMed ID: 8515352
    [No Abstract]   [Full Text] [Related]  

  • 23. Natural product drug discovery: the times have never been better.
    Galm U; Shen B
    Chem Biol; 2007 Oct; 14(10):1098-104. PubMed ID: 17961822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breakout session summary from AAPS/CRS joint workshop on critical variables in the in vitro and in vivo performance of parenteral sustained release products.
    Martinez MN; Rathbone MJ; Burgess D; Huynh M
    J Control Release; 2010 Feb; 142(1):2-7. PubMed ID: 19808069
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Presence of Mycoplasma in laboratory cell cultures from Cordoba, Argentina].
    Cumino AC; Córdoba P; Zapata TM
    Rev Argent Microbiol; 1998; 30(3):147-53. PubMed ID: 9793145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Provision and maintenance of micro-organisms for industry and international research networks.
    Smith D
    Cryo Letters; 2001; 22(2):91-6. PubMed ID: 11788847
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The art of bioprocessing.
    Jungbauer A
    Biotechnol J; 2006 Feb; 1(2):111. PubMed ID: 16892235
    [No Abstract]   [Full Text] [Related]  

  • 28. Design control and validation of a facility for sterile clinical trial preparations.
    Staines L
    J Parenter Sci Technol; 1984; 38(3):109-14. PubMed ID: 6747778
    [No Abstract]   [Full Text] [Related]  

  • 29. Automatic particle counters used for regulatory monitoring of particulates in LVPs: statistical analysis.
    Oxborrow GS; Nierman ML; Heisick JE; Lanier JM
    J Parenter Sci Technol; 1981; 35(5):237-41. PubMed ID: 7299600
    [No Abstract]   [Full Text] [Related]  

  • 30. [Usefulness of the microbiological test for the evaluation of the pyrogenic potential of infusion fluids].
    Barteczko I
    Acta Pol Pharm; 1982; 39(5-6):489-92. PubMed ID: 6820613
    [No Abstract]   [Full Text] [Related]  

  • 31. ASHP--hospital intravenous admixture program certification.
    Turco S
    Hosp Pharm; 1978 Jun; 13(6):306, 356. PubMed ID: 10307642
    [No Abstract]   [Full Text] [Related]  

  • 32. Mycoplasmal contamination of cell cultures.
    Lundin DJ
    Am Biotechnol Lab; 1994 Jul; 12(8):42. PubMed ID: 7765012
    [No Abstract]   [Full Text] [Related]  

  • 33. [A method of evaluating industrial strains of microorganisms in the microbiological synthesis industry].
    Mialina LI
    Gig Sanit; 1988 Nov; (11):46-8. PubMed ID: 3243452
    [No Abstract]   [Full Text] [Related]  

  • 34. The parenteral drug industry: recent findings.
    Fry EM
    J Parenter Sci Technol; 1982; 36(2):55-8. PubMed ID: 7077464
    [No Abstract]   [Full Text] [Related]  

  • 35. PDA's global role.
    Korczynski MS
    J Parenter Sci Technol; 1990; 44(3):111-2. PubMed ID: 2115083
    [No Abstract]   [Full Text] [Related]  

  • 36. Panel discussion: particulate matter. IV. Toxicology.
    Brewer JH
    Bull Parenter Drug Assoc; 1966; 20(2):35-7. PubMed ID: 5905226
    [No Abstract]   [Full Text] [Related]  

  • 37. Calling it 'multidose' doesn't make it so: inappropriate sharing and contamination of parenteral medication vials.
    Schaefer MK; Shehab N; Perz JF
    Am J Infect Control; 2010 Sep; 38(7):580-1. PubMed ID: 20736116
    [No Abstract]   [Full Text] [Related]  

  • 38. Aseptic processing contamination case studies and the pharmaceutical quality system.
    Friedman RL
    PDA J Pharm Sci Technol; 2005; 59(2):118-26. PubMed ID: 15971544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Virus removal from factor IX by filtration: validation of the integrity test and effect of manufacturing process conditions.
    Roberts PL; Feldman P; Crombie D; Walker C; Lowery K
    Biologicals; 2010 Mar; 38(2):303-10. PubMed ID: 20089418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Process analytical technology (PAT) for biopharmaceutical products: Part II. Concepts and applications.
    Read EK; Shah RB; Riley BS; Park JT; Brorson KA; Rathore AS
    Biotechnol Bioeng; 2010 Feb; 105(2):285-95. PubMed ID: 19731253
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.